Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

US Patent 11337971 · Granted May 24, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

D3 receptor agonist compounds; methods of preparation; intermediates thereof; an2025
Heterocyclic compounds as kinase inhibitor and uses thereof2025
Targeted nanoparticle for the treatment of traumatic brain injury and other CNS 2025
PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherap2025
Dopamine D3 receptor selective antagonists/partial agonists; method of making; a2024
Dopamine D3 receptor selective antagonists/partial agonists; method of making; a2024
Dopamine D3 receptor selective antagonists/partial agonists; method of making; a2024
Dopamine D3 receptor selective antagonists/partial agonists and uses thereof2024
Dopamine D3 receptor selective antagonists/partial agonists and uses thereof2024
Dopamine D3 receptor selective antagonists/partial agonists and uses thereof2024
PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherap2023
Potent and selective inhibitors of monoamine transporters; method of making; and2023